Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
10/15/2008 | EP1980246A1 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
10/15/2008 | EP1979355A1 Spiro imidazole derivatives as ppar modulators |
10/15/2008 | EP1979347A2 Polycyclic 1,2,3,4-tetrahydro-isoquinoline derivatives and compositions comprising them as ppar modulators |
10/15/2008 | EP1979341A1 Trisubstituted amine compound |
10/15/2008 | EP1979335A2 Thiazoles as 11 beta-hsd1 inhibitors |
10/15/2008 | EP1979331A1 Trisubstituted amine compounds as inhibitors of -cholesteryl ester transfer protein cetp |
10/15/2008 | EP1979322A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity |
10/15/2008 | EP1979318A1 Amido compounds and their use as pharmaceuticals |
10/15/2008 | EP1979316A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists |
10/15/2008 | EP1979311A2 Phenoxy acetic acids as ppar delta activators |
10/15/2008 | EP1978954A2 Use of 15-lipoxygenase inhibitors for treating obesity |
10/15/2008 | EP1978827A1 Food supplement based on group b vitamins, trace elements and w-3 and/or w-6 fatty acids and use of this food supplement in the simultaneous treatment of localized cellulite and slackening of the skin |
10/15/2008 | EP1776366B1 Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors |
10/15/2008 | EP1708726B1 Formulation for treating obesity and associated metabolic syndrome |
10/15/2008 | EP1490069B1 Alpha aed and beta aed regulation of nuclear transcription, gene regulation, and/or gene expression |
10/15/2008 | EP1476423B1 Arylsulfonamidobenzylic compounds |
10/15/2008 | EP1458723B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
10/15/2008 | EP1458722B1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
10/15/2008 | EP1453798B1 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
10/15/2008 | EP1444202B1 Novel metalloproteinase inhibitors |
10/15/2008 | EP1414421B1 The treatment of lipodystrophy with inhibitors of the renin angiotensin system |
10/15/2008 | EP1411940B1 Bridged piperidine derivatives as melanocortin receptor agonists |
10/15/2008 | EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
10/15/2008 | EP1351742B1 Compositions for inducing islet neogenesis, containing gastrin/cck receptor ligands and egf receptor ligands |
10/15/2008 | EP1308439B1 Proline derivatives and use thereof as drugs |
10/15/2008 | EP1303600B1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
10/15/2008 | EP1272515B1 Immunoregulator |
10/15/2008 | EP1206939B1 Cholesterol-lowering agents, secondary bile acid procuction inhibitors and foods and drinks |
10/15/2008 | EP1019057B1 A method of preventing or treating estrogen-dependent diseases and disorders |
10/15/2008 | EP0870036B1 Synthetic mammalian alpha-n-acetylglucosaminidase and genetic sequences encoding same |
10/15/2008 | CN101287729A GPCR agonists |
10/15/2008 | CN101287718A Substituted heteroaryl- and phenylsulfamoyl compounds |
10/15/2008 | CN101287478A Probiotics to influence fat metabolism and obesity |
10/15/2008 | CN101287476A Scavenger of harmful active oxygen and/or free radical in living body |
10/15/2008 | CN101287467A Methods and formulations for modulating Lyn kinase activity and treating related disorders |
10/15/2008 | CN101285030A Brewing method of special vinegar for reducing blood sugar |
10/15/2008 | CN101284859A Panaxadiol saponin microbial conversion hydrolysate and method for preparing same |
10/15/2008 | CN101284858A Panaxadiol saponin microbial conversion products and method for preparing same |
10/15/2008 | CN101284818A Solid forms of (E) -1- (4- ( (1R, 2S, 3R) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl) ethanone oxime |
10/15/2008 | CN101284810A Cyano-pyrrolidine and cyano-tetrahydrothiazole derivates |
10/15/2008 | CN101284135A Mono-modified polyethyleneglycol-insulin complexes and preparation method thereof |
10/15/2008 | CN101284129A Composition containing lactase and vitamin D |
10/15/2008 | CN101284105A Thrombolysis lipid-lowering pellet for curing cardio-cerebrovascular disease |
10/15/2008 | CN101284101A Chinese traditional medicine for curing fatty liver and hyperlipemia |
10/15/2008 | CN101284092A Medicinal composition for preventing birth defect and improving the memory |
10/15/2008 | CN101284091A Externally used Chinese proprietary medicine for curing diabetes and preparation method thereof |
10/15/2008 | CN101284078A Nicandra physalodes (simple recipe) decocted in water for curing cardiovascular disease |
10/15/2008 | CN101284064A Preparation method of Gelan lipid-reducing antialcoholic drug |
10/15/2008 | CN101284062A Weight reduction bellyband and preparation method thereof |
10/15/2008 | CN101284055A Medicine for curing diabetes |
10/15/2008 | CN101284038A Health care food for increasing bone density |
10/15/2008 | CN101284027A Preparation method of capsules for reducing blood fat |
10/15/2008 | CN101284025A Novel technique for preparing oyster shell active calcium capsules |
10/15/2008 | CN101284017A A method for continuously preparing birds nest extract with narrow molecular weight distribution by enzymolysis and membrane filtration coupling technique |
10/15/2008 | CN101284014A Inverted sugar electrolytes injection and preparation technique thereof |
10/15/2008 | CN101284003A Medicinal composition containing andrographolide derivatives and preparation method thereof and application |
10/15/2008 | CN101284001A Application of mangiferin in treating type II diabetes and vitro trial model thereof |
10/15/2008 | CN101284000A Therapeutic agents for adiposity or fatty liver |
10/15/2008 | CN101283995A Different pharmaceutical uses alpha2delta ligands |
10/15/2008 | CN101283993A Use of the diabecron sustained-release tablet in treating the type 2 diabetes mellitus |
10/15/2008 | CN101283982A Fenofibrate nanometer suspension and preparation method thereof |
10/15/2008 | CN101283819A Xylitol seabuckthorn fruit juice drink |
10/15/2008 | CN101283807A PUFA supplements |
10/15/2008 | CN101283799A Preparation method of health food for adjusting the blood fat |
10/15/2008 | CN101283761A Smallanthus sonchifolius fruit extract and extracting method and application |
10/15/2008 | CN101283717A Flower silk leaf bagged tea and its preparation method |
10/15/2008 | CN100425608C Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic |
10/15/2008 | CN100425592C Indole derivatives |
10/15/2008 | CN100425282C Y2/Y4 selective receptor agonists for therapeutic interventions |
10/15/2008 | CN100425261C Chongcao Emiao oil capsules and preparation thereof |
10/15/2008 | CN100425166C Cactus beverage with fat-reducing and beauty function |
10/15/2008 | CN100425161C A fat-reducing food additive and application thereof |
10/14/2008 | US7435872 Role of p62 in aging-related disease |
10/14/2008 | US7435756 Preparation and diabetic use of gibberellins |
10/14/2008 | US7435744 Brain disorders; central nervous system disorders; viricides |
10/14/2008 | US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder |
10/14/2008 | US7435729 using estrogen antagonist ; anticancer agents |
10/14/2008 | US7435725 Oral compositions and methods for prevention, reduction and treatment of radiation injury |
10/14/2008 | CA2497345C Novel quaternary ammonium compounds |
10/14/2008 | CA2494177C Azulene derivatives and salts thereof for use as na+-glucose cotransporter inhibitors |
10/14/2008 | CA2445145C Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes |
10/14/2008 | CA2331395C Fatty acid analogues for the treatment of diabetes |
10/14/2008 | CA2318128C Oral liquid compositions |
10/14/2008 | CA2190394C Recombinant viruses, preparation and use thereof in gene therapy |
10/14/2008 | CA2171625C Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents |
10/09/2008 | WO2008121592A2 Acetyl coenzyme a carboxylase inhibitors |
10/09/2008 | WO2008121570A1 Compounds and methods for modulating g protein-coupled receptors |
10/09/2008 | WO2008121064A1 New imidazo[4,5-b]pyridine-6-halo-7-aryl/heteroaryl compounds 705 |
10/09/2008 | WO2008121063A1 New imidazo[ 4,5-b]pyridine-7-carboxamides 704 |
10/09/2008 | WO2008121009A1 Modified adiponectin proteins |
10/09/2008 | WO2008121006A1 Selenium administration |
10/09/2008 | WO2008120813A1 Combined use of dipeptidyl peptidase iv inhibitor compound and sweetener |
10/09/2008 | WO2008120797A1 Ampk activator |
10/09/2008 | WO2008120778A1 Composition for promoting ketone compound formation |
10/09/2008 | WO2008120765A1 Analgesic composition |
10/09/2008 | WO2008120761A1 Heteroaryl derivative |
10/09/2008 | WO2008120759A1 Urea compound and use thereof |
10/09/2008 | WO2008120754A1 Picolinamide compound |
10/09/2008 | WO2008120744A1 Five-membered cyclic amide compound and use thereof |
10/09/2008 | WO2008120717A1 Liquid nutritional composition containing sodium at high concentration and method of producing the same |